Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Preclinical studies validate Nabi's novel approach to treating and preventing nicotine addiction

Dec. 20, 1999

Novartis reports setbacks and advances in the development of new chelating agents

Dec. 8, 1999

Glaxo Wellcome's Zyban approved in The Netherlands for smoking cessation

Dec. 3, 1999

Neuronal nicotinic acetylcholine receptor ligands in early development at Pfizer

Nov. 30, 1999

Pfizer discloses modulators of cholinergic function for smoking cessation, etc.

Nov. 29, 1999

Development of potential new antiaddictive agent supported by NIDA

Oct. 22, 1999

FDA accepts DigiTAb filing for review

Oct. 15, 1999

Schein to license proprietary chelating compound from SunPharm

Oct. 8, 1999

Carbamazepine for the prevention and treatment of alcohol withdrawal syndrome

Sep. 28, 1999

NIDA study sheds new insight on cocaine addiction process

Sep. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...